152 related articles for article (PubMed ID: 26407907)
1. Restoration of IGF2 imprinting by polycomb repressive complex 2 docking factor SUZ12 in colon cancer cells.
Wang H; Ge S; Qian G; Li W; Cui J; Wang G; Hoffman AR; Hu JF
Exp Cell Res; 2015 Nov; 338(2):214-21. PubMed ID: 26407907
[TBL] [Abstract][Full Text] [Related]
2. Promoter histone H3K27 methylation in the control of IGF2 imprinting in human tumor cell lines.
Li T; Chen H; Li W; Cui J; Wang G; Hu X; Hoffman AR; Hu J
Hum Mol Genet; 2014 Jan; 23(1):117-28. PubMed ID: 23962719
[TBL] [Abstract][Full Text] [Related]
3. CTCF regulates allelic expression of Igf2 by orchestrating a promoter-polycomb repressive complex 2 intrachromosomal loop.
Li T; Hu JF; Qiu X; Ling J; Chen H; Wang S; Hou A; Vu TH; Hoffman AR
Mol Cell Biol; 2008 Oct; 28(20):6473-82. PubMed ID: 18662993
[TBL] [Abstract][Full Text] [Related]
4. Interruption of intrachromosomal looping by CCCTC binding factor decoy proteins abrogates genomic imprinting of human insulin-like growth factor II.
Zhang H; Niu B; Hu JF; Ge S; Wang H; Li T; Ling J; Steelman BN; Qian G; Hoffman AR
J Cell Biol; 2011 May; 193(3):475-87. PubMed ID: 21536749
[TBL] [Abstract][Full Text] [Related]
5. Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells.
Zhao X; Liu X; Wang G; Wen X; Zhang X; Hoffman AR; Li W; Hu JF; Cui J
Oncotarget; 2016 Aug; 7(32):51349-51364. PubMed ID: 27275535
[TBL] [Abstract][Full Text] [Related]
6. CRISPR Cas9-guided chromatin immunoprecipitation identifies miR483 as an epigenetic modulator of IGF2 imprinting in tumors.
Zhang Y; Hu JF; Wang H; Cui J; Gao S; Hoffman AR; Li W
Oncotarget; 2017 May; 8(21):34177-34190. PubMed ID: 27486969
[TBL] [Abstract][Full Text] [Related]
7. Induced DNA demethylation can reshape chromatin topology at the IGF2-H19 locus.
Ito Y; Nativio R; Murrell A
Nucleic Acids Res; 2013 May; 41(10):5290-302. PubMed ID: 23585276
[TBL] [Abstract][Full Text] [Related]
8. Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells.
Vu TH; Nguyen AH; Hoffman AR
Hum Mol Genet; 2010 Mar; 19(5):901-19. PubMed ID: 20015958
[TBL] [Abstract][Full Text] [Related]
9. CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues.
Ulaner GA; Yang Y; Hu JF; Li T; Vu TH; Hoffman AR
Endocrinology; 2003 Oct; 144(10):4420-6. PubMed ID: 12960026
[TBL] [Abstract][Full Text] [Related]
10. Intrachromosomal Looping and Histone K27 Methylation Coordinately Regulates the lncRNA
Wen X; Zhang Q; Zhou L; Li Z; Wei X; Yang W; Zhang J; Li H; Xu Z; Cui X; Zhang S; Wang Y; Li W; Hoffman AR; Liu Z; Hu JF; Cui J
Cells; 2022 Oct; 11(19):. PubMed ID: 36231092
[TBL] [Abstract][Full Text] [Related]
11. Polycomb repressive complex 2 epigenomic signature defines age-associated hypermethylation and gene expression changes.
Dozmorov MG
Epigenetics; 2015; 10(6):484-95. PubMed ID: 25880792
[TBL] [Abstract][Full Text] [Related]
12. IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch.
Li T; Vu TH; Ulaner GA; Littman E; Ling JQ; Chen HL; Hu JF; Behr B; Giudice L; Hoffman AR
Mol Hum Reprod; 2005 Sep; 11(9):631-40. PubMed ID: 16219628
[TBL] [Abstract][Full Text] [Related]
13. Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms' tumor.
Vu TH; Hoffman A
J Biol Chem; 1996 Apr; 271(15):9014-23. PubMed ID: 8621549
[TBL] [Abstract][Full Text] [Related]
14. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.
Kirmizis A; Bartley SM; Kuzmichev A; Margueron R; Reinberg D; Green R; Farnham PJ
Genes Dev; 2004 Jul; 18(13):1592-605. PubMed ID: 15231737
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sites.
Yang Y; Hu JF; Ulaner GA; Li T; Yao X; Vu TH; Hoffman AR
J Cell Biochem; 2003 Dec; 90(5):1038-55. PubMed ID: 14624463
[TBL] [Abstract][Full Text] [Related]
16. Impairment of IGF2 gene expression in prostate cancer is triggered by epigenetic dysregulation of IGF2-DMR0 and its interaction with KLF4.
Schagdarsurengin U; Lammert A; Schunk N; Sheridan D; Gattenloehner S; Steger K; Wagenlehner F; Dansranjavin T
Cell Commun Signal; 2017 Oct; 15(1):40. PubMed ID: 29017567
[TBL] [Abstract][Full Text] [Related]
17. Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia.
Paradowska A; Fenic I; Konrad L; Sturm K; Wagenlehner F; Weidner W; Steger K
Int J Oncol; 2009 Jul; 35(1):87-96. PubMed ID: 19513555
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic alterations contribute to promoter activity of imprinting gene IGF2.
Zheng QF; Xu B; Wang HM; Ding LH; Liu JY; Zhu LY; Qiu H; Zhang L; Ni GY; Ye J; Gao SB; Jin GH
Biochim Biophys Acta Gene Regul Mech; 2018 Feb; 1861(2):117-124. PubMed ID: 29413895
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for cancer through adenovirus vector‑mediated expression of the Ad5 early region gene 1A based on loss of IGF2 imprinting.
Pan Y; He B; Lirong Z; Nie Z; Chen L; Gu L; Hoffman AR; Wang S; Hu J
Oncol Rep; 2013 Oct; 30(4):1814-22. PubMed ID: 23900345
[TBL] [Abstract][Full Text] [Related]
20. Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site.
Ulaner GA; Vu TH; Li T; Hu JF; Yao XM; Yang Y; Gorlick R; Meyers P; Healey J; Ladanyi M; Hoffman AR
Hum Mol Genet; 2003 Mar; 12(5):535-49. PubMed ID: 12588801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
